BPG is committed to discovery and dissemination of knowledge
Articles in Press
3/11/2026 8:49:24 AM | Browse: 2 | Download: 0
Publication Name World Journal of Transplantation
Manuscript ID 118288
Country United States
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Immunosuppression and vascular remodeling after liver transplantation: Mechanisms, surrogate markers, and modifiable pathways
Manuscript Source Invited Manuscript
All Author List Sarah Jahangir, Mohammed Zohery, Clarimar Diaz Lopez, Jenna Carter Hamed, Shiza Sarfraz, Hafsa Ashraf, Taha Rafiq, Hadeera Ali, Muhammad Raza, Dushyant Singh Dahiya, Mohamed Khalaf and Hassam Ali
Funding Agency and Grant Number
Corresponding Author Hassam Ali, MD, Division of Gastroenterology, Hepatology and Nutrition, East Carolina University - Brody School of Medicine, 2100 Statonsburg Road, Greenville, NC 27834, United States. hassamali155@gmail.com
Key Words Liver transplantation; Immunosuppression; Vascular remodeling; Endothelial dysfunction; Cardiovascular disease; Calcineurin inhibitors; Metabolic complications; Arterial stiffness; Graft survival
Core Tip Long-term survival after liver transplantation is increasingly limited by cardiovascular disease driven by immunosuppression-associated vascular remodeling. This review highlights how commonly used immunosuppressive agents, particularly calcineurin inhibitors and corticosteroids, promote endothelial dysfunction, arterial stiffening, and metabolic injury, while alternative strategies such as mammalian target of rapamycin inhibitor-based regimens and antimetabolites may reduce vascular harm. We emphasize noninvasive vascular markers and individualized immunosuppression as emerging tools to balance graft protection with long-term cardiovascular health in liver transplant recipients.
Citation Jahangir S, Zohery M, Diaz Lopez C, Hamed JC, Sarfraz S, Ashraf H, Rafiq T, Ali H, Raza M, Dahiya DS, Khalaf M, Ali H. Immunosuppression and vascular remodeling after liver transplantation: Mechanisms, surrogate markers, and modifiable pathways World J Transplant 2026; In press
Received
2025-12-29 01:26
Peer-Review Started
2025-12-29 01:26
First Decision by Editorial Office Director
2026-01-14 08:25
Return for Revision
2026-01-14 08:25
Revised
2026-02-02 17:12
Publication Fee Transferred
Second Decision by Editor
2026-03-11 02:35
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-03-11 08:49
Articles in Press
2026-03-11 08:49
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2220-3230 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © Author(s) (or their employer(s)) 2026. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com